Literature DB >> 8388892

Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein-Barr virus viral capsid antigens.

D L Wiedbrauk1, S Bassin.   

Abstract

Five enzyme immunoassays for the detection of Epstein-Barr virus immunoglobulin M were evaluated versus indirect immunofluorescence assays with 128 serum specimens. The sensitivities and specificities, respectively, of these kits were as follows: Gull, 92 and 100%; Incstar, 53 and 100%; Ortho, 89 and 100%; Sigma, 78 and 86%; and BioWhittaker, 94 and 70%. Indeterminate results were produced by 2, 2, 0, 8, and 14 specimens with the Gull, Incstar, Ortho, Sigma, and BioWhittaker tests, respectively. The Gull and Sigma tests had the best day-to-day reproducibilities, and the Gull test was the easiest to use. No correlation between immunofluorescence titers and enzyme immunoassay values was observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388892      PMCID: PMC262933          DOI: 10.1128/jcm.31.5.1339-1341.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Incidence of heterophil antibody responses in children with infectious mononucleosis.

Authors:  G Fleisher; E T Lennette; G Henle; W Henle
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

2.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

Authors:  G Henle; W Henle; V Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

Review 3.  Epstein-Barr virus and human diseases: recent advances in diagnosis.

Authors:  M Okano; G M Thiele; J R Davis; H L Grierson; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

4.  Primary Epstein-Barr virus infections in children.

Authors:  C V Sumaya
Journal:  Pediatrics       Date:  1977-01       Impact factor: 7.124

  4 in total
  8 in total

Review 1.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

2.  Reliability of four methods for the diagnosis of acute infection by Epstein-Barr virus.

Authors:  J Gutiérrez; M Rodríguez; C Maroto; G Piédrola
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

3.  Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation.

Authors:  M Buisson; B Fleurent; M Mak; P Morand; L Chan; A Ng; M Guan; D Chin; J M Seigneurin
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection.

Authors:  A Svahn; M Magnusson; L Jägdahl; L Schloss; G Kahlmeter; A Linde
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

5.  Heterophile antibody positive infectious mononucleosis.

Authors:  Baijayantimala Mishra; Balvinder Mohan; R K Ratho
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

6.  Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.

Authors:  Barbara C Gärtner; Ralf D Hess; Dirk Bandt; Alexander Kruse; Axel Rethwilm; Klaus Roemer; Nikolaus Mueller-Lantzsch
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

7.  Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.

Authors:  Alvaro Guerrero-Ramos; Mauli Patel; Kinjal Kadakia; Tanzina Haque
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

8.  Cytomegalic hepatitis in a patient receiving omalizumab.

Authors:  R Gonçalves; C Valente; E Ferreira; J E Serra; J Saraiva da Cunha
Journal:  IDCases       Date:  2016-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.